Fingerprint
Dive into the research topics of 'Dapagliflozin effects on haematocrit, red blood cell count and reticulocytes in insulin-treated patients with type 2 diabetes'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Dapagliflozin effects on haematocrit, red blood cell count and reticulocytes in insulin-treated patients with type 2 diabetes
Jens Aberle, Markus Menzen, Sebastian M. Schmid, Christoph Terkamp, Elmar Jaeckel, Katja Rohwedder, Markus F. Scheerer, John Xu, Weifeng Tang, Andreas L. Birkenfeld*
*Corresponding author for this work
- Universitatsklinikum Hamburg-Eppendorf und Medizinische Fakultat
- Community Hospital Bonn
- Institut für Integrative und ExperimentelleGenomik
- German Center for Diabetes Research
- Medizinische Hochschule Hannover (MHH)
- Statistical Innovation Group
- University of Tuebingen
- Department of Diabetology
- Departments of Diabetes
- King's College London
Research output: Contribution to journal › Article › peer-review
25
Citations
(Scopus)